Projects per year
Personal profile
Education
- 2005 Ph.D. (Anatomy and Cell Biology), Queen's University, Kingston, Ontario, Canada
- 1997 B.S.(Biochemistry), Queen's University, Kingston, Ontario, Canada
Experience
- 2019- Associate Professor, Graduate Institute of Biomedical Informatics, Taipei Medical University
-
2013- Associate Professor, The Ph.D. Program for Translational Medicine, Taipei Medical University
- 2012-2013 Assistant Professor, The Ph.D. Program for Translational Medicine, Taipei Medical University
- 2008-2012 Assoistant Professor, Department of Radiology, Taipei Medical University
- 2010 Visiting scholar to Dr. Andrew Kung’s lab at Dana Farber Cancer Institute
Research Interests
- Cancer/stem cell biology
- Translational research
- New drug/therapeutic strategy development
- Regenerative medicine
- Biology and applications of extracellular vesicles
Related Link
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
A Translational Exploration of Anisomelic Acid'S Potential in Reprogramming Tumor Immune Microenvironment (Time) via Regulating Exosomal Biogenesis to Overcome Immune Checkpoint Inhibitor (Ici) Resistance Mediated by Head and Neck Cancer Stem Cells
Wu, A. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
Leveraging Cardiac Protective Peptides (Cpps) to Augment Msc-Derived Small Extracellular Vesicles Potentials for Precision Myocardial Infarction Therapy and Prevention( I )
Wu, A. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
A Translational Investigation of Generating Enhanced Mscs and Secretome Using Mfp-Based Proprietary Culture Methods for Dcli Treatment(3/3)
Wu, A. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
A Translational Exploration of Anisomelic Acid'S Potential in Reprogramming Tumor Immune Microenvironment (Time) to Overcome Immune Checkpoint Inhibitor (Ici) Resistance Mediated by Head and Neck Cancer Stem Cells
Wu, A. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
A Translational Investigation of Generating Enhanced Mscs and Secretome Using Mfp-Based Proprietary Culture Methods for Dcli Treatment(2/3)
Wu, A. (PI)
8/1/23 → 7/31/24
Project: A - Government Institution › b - National Science and Technology Council
-
Corrigendum “Preclinical anti-inflammatory and antioxidant effects of Azanza garckeana in STZ-induced glycemic-impaired rats, and pharmacoinformatics of it major phytoconstituents”(Biomedicine & Pharmacotherapy, (2022), 152, C, (113196), (S0753332222005856), 10.1016/j.biopha.2022.113196)
Lawal, B., Sani, S., Onikanni, A. S., Ibrahim, Y. O., Agboola, A. R., Lukman, H. Y., Olawale, F., Jigam, A. A., Batiha, G. E. S., Babalola, S. B., Gomaa, M. H., Lima, C. M. G., Wu, A. T. H., Huang, H. S. & Conte-Junior, C. A., 2026, (Accepted/In press) In: Biomedicine and Pharmacotherapy. 199, 119308.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Ovatodiolide overcomes cisplatin resistance in head and neck cancer by disrupting a novel oncogenic signature and cancer-associated fibroblast activation
Yang, C. H., Renantha, R. R., Hsu, P. C., Wu, A. T., Wu, S. Y., Azizah, N., Ritmaleni, R., Chen, J. H., Lee, J. C., Fang, C. Y. & Lin, K. C., Jan 2026, In: Journal of Dental Sciences. 21, 1, p. 282-293 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Pathology-tailored nanotherapy via Galectin-3-targeted and triple-responsive nanoparticles enables multimodal therapy against aortic dissection
Lin, C., Tsai, M. L., Chao, H. Y., Cheng, T. M., Shih, C. M., Wu, A. T. H., Cheng, C. H., Hsiao, C. Y., Lu, H. Y., Shih, C. C. & Mi, F. L., Dec 2026, In: Journal of Nanobiotechnology. 24, 1, 41.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Citations (Scopus) -
Bioprospection of Hura crepitans metabolites against oxidative stress and inflammation: An in vitro and in silico exploration
Kuo, Y. C., Lawal, B., Lukman, H. Y., Chen, L. C., Huang, S. L., Chen, Y. F., Fadaka, A. O., Olawale, F., Olasupo, A., Ajenifujah, O. T., Fouad, D., Papadakis, M., Batiha, G. E. S., Sabiu, S., Wu, A. T. H. & Huang, H. S., 2025, In: International Journal of Medical Sciences. 22, 8, p. 1837-1851 15 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Computer-aided drug discovery of a dual-target inhibitor for ovarian cancer: therapeutic intervention targeting CDK1/TTK signaling pathway and structural insights in the NCI-60
Tang, S. L., Sumitra, M. R., Kuo, Y. C., Hsu, H. L., Ansar, M., Huang, S. L., Lee, S. Y., Wang, H. J., Lawal, B., Wu, A. T. H., Chen, L. C. & Huang, H. S., Jul 2025, In: Computers in Biology and Medicine. 193, 110445.Research output: Contribution to journal › Article › peer-review
2 Link opens in a new tab Citations (Scopus)
Datasets
-
Additional file 1 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Chou, P.-C. (Contributor), Wu, A. T. H. (Creator), Sung, P.-L. (Contributor), Huang, C.-Y. F. (Contributor), Lin, J.-H. (Contributor), Wen, K.-C. (Creator), Yeung, S.-C. J. (Contributor) & Lee, M.-H. (Contributor), Figshare, 2020
DOI: 10.6084/m9.figshare.12845522.v1, https://doi.org/10.6084%2Fm9.figshare.12845522.v1
Dataset
-
Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer
Lee, M.-H. (Contributor), Yeung, S.-C. J. (Contributor), Chou, P.-C. (Contributor), Lin, J.-H. (Contributor), Wen, K.-C. (Creator), Huang, C.-Y. F. (Contributor), Sung, P.-L. (Contributor) & Wu, A. T. H. (Creator), Figshare, 2020
DOI: 10.6084/m9.figshare.c.5099513.v1, https://doi.org/10.6084%2Fm9.figshare.c.5099513.v1
Dataset
-
Supplementary_Figure_1_Characterization_of_U87MG - The Development and Applications of a Dual Optical Imaging System for Studying Glioma Stem Cells
Wen, Y.-T. (Creator), Hsiao, M. (Creator), Huynh, T.-T. (Contributor), Lin, C.-M. (Creator), Tai, P.-A. (Contributor), Wu, A. T. H. (Creator), Wei, L. (Creator) & Liu, Y.-L. (Contributor), SAGE Journals, 2019
DOI: 10.25384/sage.9767339.v1, https://doi.org/10.25384%2Fsage.9767339.v1
Dataset
-
Additional file 1: Table S1. of Glucose transporter 4 promotes head and neck squamous cell carcinoma metastasis through the TRIM24-DDX58 axis
Chang, W.-M. (Creator), Hsiao, M. (Creator), Su, C.-Y. (Contributor), Chang, P.M.-H. (Creator), Lin, Y.-F. (Contributor), Wu, A. T. H. (Creator), Chen, C.-L. (Creator), Chi, L.-H. (Contributor), Chen, M.-H. (Creator) & Chang, Y.-C. (Creator), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3660368_d1.v1, https://doi.org/10.6084%2Fm9.figshare.c.3660368_d1.v1
Dataset
-
Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways
Huang, Y.-J. (Contributor), Yang, C.-K. (Contributor), Wei, P.-L. (Contributor), Huynh, T.-T. (Contributor), Whang-Peng, J. (Creator), Meng, T.-C. (Contributor), Hsiao, M. (Creator), Tzeng, Y.-M. (Contributor), Wu, A. T. (Creator) & Yen, Y. (Creator), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3704533.v1, https://doi.org/10.6084%2Fm9.figshare.c.3704533.v1
Dataset